<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK537720" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK537720/" /><meta name="ncbi_pagename" content="VPS13D Movement Disorder - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>VPS13D Movement Disorder - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="VPS13D Movement Disorder" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/02/21" /><meta name="citation_author" content="Inge A Meijer" /><meta name="citation_pmid" content="30789691" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK537720/" /><meta name="citation_keywords" content="Spinocerebellar Ataxia, Recessive, Type 4 (SCAR4)" /><meta name="citation_keywords" content="Spinocerebellar Ataxia with Saccadic Intrusion (SCASI)" /><meta name="citation_keywords" content="VPS13D Hyperkinetic Movement Disorder" /><meta name="citation_keywords" content="VPS13D Hyperkinetic Movement Disorder" /><meta name="citation_keywords" content="Spinocerebellar Ataxia with Saccadic Intrusion (SCASI)" /><meta name="citation_keywords" content="Spinocerebellar Ataxia, Recessive, Type 4 (SCAR4)" /><meta name="citation_keywords" content="Vacuolar protein sorting-associated protein 13D" /><meta name="citation_keywords" content="VPS13D" /><meta name="citation_keywords" content="VPS13D Movement Disorder" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="VPS13D Movement Disorder" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Inge A Meijer" /><meta name="DC.Date" content="2019/02/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK537720/" /><meta name="description" content="VPS13D movement disorder is a hyperkinetic movement disorder (dystonia, chorea, and/or ataxia) of variable age of onset that can be associated with developmental delay. Onset ranges from birth to adulthood. Individuals can present in childhood with motor delays and gait instability. Cognitive impairment ranging from mild intellectual disability to developmental delay has been reported, and several individuals have normal cognitive function. Individuals have also presented as young adults with gait difficulties caused by spastic ataxia or ataxia. In addition to gait ataxia, affected individuals had limb ataxia, dysarthria, and eye movement abnormalities (macro-saccadic oscillations, nystagmus, and saccadic pursuit). Additional features reported in some individuals include peripheral neuropathy and/or seizures. The disorder progresses to spastic ataxia or generalized dystonia, which can lead to loss of independent ambulation." /><meta name="og:title" content="VPS13D Movement Disorder" /><meta name="og:type" content="book" /><meta name="og:description" content="VPS13D movement disorder is a hyperkinetic movement disorder (dystonia, chorea, and/or ataxia) of variable age of onset that can be associated with developmental delay. Onset ranges from birth to adulthood. Individuals can present in childhood with motor delays and gait instability. Cognitive impairment ranging from mild intellectual disability to developmental delay has been reported, and several individuals have normal cognitive function. Individuals have also presented as young adults with gait difficulties caused by spastic ataxia or ataxia. In addition to gait ataxia, affected individuals had limb ataxia, dysarthria, and eye movement abnormalities (macro-saccadic oscillations, nystagmus, and saccadic pursuit). Additional features reported in some individuals include peripheral neuropathy and/or seizures. The disorder progresses to spastic ataxia or generalized dystonia, which can lead to loss of independent ambulation." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK537720/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/vps13d-md/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK537720/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D2DFDE03FE9E100000000055101B2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK537720_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK537720_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/vldlr-ch/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/vps35-pd/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK537720_"><span class="title" itemprop="name"><i>VPS13D</i> Movement Disorder</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Spinocerebellar Ataxia, Recessive, Type 4 (SCAR4); Spinocerebellar Ataxia with Saccadic Intrusion (SCASI); <i>VPS13D</i> Hyperkinetic Movement Disorder</div><p class="contrib-group"><span itemprop="author">Inge A Meijer</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK537720_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK537720_ai__"><div class="contrib half_rhythm"><span itemprop="author">Inge A Meijer</span>, MD, PhD<div class="affiliation small">CHU Sainte-Justine<br />Universit&#x000e9; de Montr&#x000e9;al<br />Montr&#x000e9;al, Qu&#x000e9;bec, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.laertnomu@rejiem.egni" class="oemail">ac.laertnomu@rejiem.egni</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 21, 2019</span>.</p><p><em>Estimated reading time: 14 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="vps13d-md.Summary" itemprop="description"><h2 id="_vps13d-md_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>VPS13D</i> movement disorder is a hyperkinetic movement disorder (dystonia, chorea, and/or ataxia) of variable age of onset that can be associated with developmental delay. Onset ranges from birth to adulthood. Individuals can present in childhood with motor delays and gait instability. Cognitive impairment ranging from mild intellectual disability to developmental delay has been reported, and several individuals have normal cognitive function. Individuals have also presented as young adults with gait difficulties caused by spastic ataxia or ataxia. In addition to gait ataxia, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals had limb ataxia, dysarthria, and eye movement abnormalities (macro-saccadic oscillations, nystagmus, and saccadic pursuit). Additional features reported in some individuals include peripheral neuropathy and/or seizures. The disorder progresses to spastic ataxia or generalized dystonia, which can lead to loss of independent ambulation.</p></div><div><h4 class="inline">Diagnosis.</h4><p>The diagnosis of <i>VPS13D</i> movement disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>VPS13D</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Standard treatment for seizures; spasticity treatments include baclofen, tizanidine, benzodiazepines, dantrolene sodium, gabapentin, botulinum toxin injections, and intrathecal baclofen; treatment options for dystonia include trihexyphenidyl, botulinum toxin injections, benzodiazepines, baclofen, and levodopa. A multidisciplinary team including occupational and physical therapists and a physiatrist is important; supportive developmental therapies should be provided as needed.</p><p><i>Surveillance:</i> Monitor for urinary urgency, contractures, and seizures; evaluate fall risk and gait stability; monitor developmental progress and educational needs.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>VPS13D</i> movement disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <i>VPS13D</i> pathogenic variants in the family are known.</p></div></div><div id="vps13d-md.Diagnosis"><h2 id="_vps13d-md_Diagnosis_">Diagnosis</h2><div id="vps13d-md.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>VPS13D</i> movement disorder <b>should be suspected</b> in individuals with the following clinical, laboratory, and imaging findings.</p><p><b>Clinical presentation</b></p><ul><li class="half_rhythm"><div>Infantile-onset hypotonia and severe developmental delay or motor delay that progresses to severe generalized dystonia or spastic ataxia</div></li><li class="half_rhythm"><div>Childhood-onset chorea or dystonia</div></li><li class="half_rhythm"><div>Early-adulthood-onset progressive spastic ataxia, dystonia, and myoclonus</div></li></ul><p><b>Additional clinical features</b></p><ul><li class="half_rhythm"><div>Macro-saccadic intrusions; these large abnormal back-and-forth eye movements with stationary inter-saccadic intervals are often triggered by saccades.</div></li><li class="half_rhythm"><div>Pyramidal signs (e.g., hyperreflexia, Babinski signs)</div></li><li class="half_rhythm"><div>Peripheral axonal neuropathy</div></li><li class="half_rhythm"><div>Seizures</div></li></ul><p><b>Laboratory findings</b></p><ul><li class="half_rhythm"><div>Elevated CSF lactate (in 1 individual) [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>]</div></li><li class="half_rhythm"><div>Enlarged mitochondria with altered morphology on muscle biopsy; identified in the only individual evaluated by muscle biopsy [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>, <a class="bk_pop" href="#vps13d-md.REF.seong.2018.1075">Seong et al 2018</a>]</div></li></ul><p><b>Brain MRI findings</b></p><ul><li class="half_rhythm"><div>Symmetric T<sub>2</sub>-weighted and FLAIR hyperintensities in the caudate and putamen</div></li><li class="half_rhythm"><div>Hyperintense T<sub>2</sub>-weighted and FLAIR signal abnormalities of periventricular and subcortical regions</div></li><li class="half_rhythm"><div>Hypointense basal ganglia (globus pallidus)</div></li><li class="half_rhythm"><div>Thin corpus callosum [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>]</div></li><li class="half_rhythm"><div>Mild cerebellar atrophy, often involving the vermis [<a class="bk_pop" href="#vps13d-md.REF.seong.2018.1075">Seong et al 2018</a>]</div></li></ul><p>Note: Brain MRI findings can be striking, but imaging results vary among individuals with <i>VPS13D</i> movement disorder. Imaging findings can resemble those seen in <a href="/books/n/gene/narp/">Leigh syndrome</a>. Some individuals with <i>VPS13D</i> movement disorder have had normal brain MRI examinations.</p></div><div id="vps13d-md.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>VPS13D</i> movement disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>VPS13D</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK537720/table/vps13d-md.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figvps13dmdTmoleculargenetictestingus" rid-ob="figobvps13dmdTmoleculargenetictestingus">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>VPS13D</i> movement disorder is broad, individuals with the distinctive findings described in <a href="#vps13d-md.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#vps13d-md.Option_1">Option 1</a>), whereas those with a phenotype indistinguishable from many other inherited disorders with developmental delay and/or movement disorder are more likely to be diagnosed using genomic testing (see <a href="#vps13d-md.Option_2">Option 2</a>).</p><div id="vps13d-md.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of <i>VPS13D</i> movement disorder, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>VPS13D</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>VPS13D</i> and other genes of interest (see <a href="#vps13d-md.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the relatively recent description of <i>VPS13D</i> movement disorder, some panels for developmental delay and/or movement disorder may not yet include this gene. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="vps13d-md.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from many other inherited disorders characterized by developmental delay and/or movement disorder, <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="vps13d-md.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>VPS13D</i> Movement Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537720/table/vps13d-md.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps13d-md.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vps13d-md.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_vps13d-md.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_vps13d-md.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup><br />Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_vps13d-md.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>VPS13D</i></td><td headers="hd_h_vps13d-md.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_vps13d-md.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23/24&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_vps13d-md.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_vps13d-md.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1/24&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="vps13d-md.TF.1.1"><p class="no_margin">See <a href="/books/n/gene/VPS13D-rmd/#VPS13D-rmd.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="vps13d-md.TF.1.2"><p class="no_margin">See <a href="#vps13d-md.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="vps13d-md.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="vps13d-md.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al [2018]</a>, <a class="bk_pop" href="#vps13d-md.REF.seong.2018.1075">Seong et al [2018]</a></p></div></dd><dt>5. </dt><dd><div id="vps13d-md.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="vps13d-md.TF.1.6"><p class="no_margin">Partial <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of <i>VPS13D</i> exons 24 to 30 was reported in one family [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>].</p></div></dd></dl></div></div></div></div></div></div><div id="vps13d-md.Clinical_Characteristics"><h2 id="_vps13d-md_Clinical_Characteristics_">Clinical Characteristics</h2><div id="vps13d-md.Clinical_Description"><h3>Clinical Description</h3><p>To date, 19 individuals from 12 families have been identified with <i>VPS13D</i> movement disorder. This disorder is characterized by hyperkinetic movement (dystonia, chorea, or ataxia) of variable onset that can be associated with developmental delay. Onset ranging from birth to age 39 years has been reported. Eleven individuals presented in childhood with mainly motor delays and gait instability. Of those, two individuals had arm tremor, one had chorea, and one had torticollis at presentation. Eight individuals presented as young adults with gait difficulties caused by spastic ataxia or ataxia. In addition to gait ataxia, those presenting in young adulthood also had limb ataxia, dysarthria, and eye movement abnormalities (macro-saccadic oscillations, nystagmus, and saccadic pursuit). The disorder progresses to spastic ataxia or generalized dystonia, which can lead to loss of independent ambulation.</p><p><b>Developmental delay.</b> Eleven individuals presented as children with mainly motor delay. However, four individuals have mild intellectual disability and two have developmental delay.</p><p><b>Movement disorder.</b> Dystonia in reported individuals has included generalized dystonia, cervical dystonia, laryngeal dystonia, and bibrachial dystonia with tremor. Other movement disorders reported include chorea and, more rarely, stereotypies and myoclonus.</p><p><b>Pyramidal signs.</b> Most individuals had hyperreflexia, extensor cutaneous plantar signs, and lower-limb (more than upper-limb) spasticity.</p><p><b>Peripheral neuropathy</b> has been reported and is characterized by decreased or absent ankle reflexes (in 2 families) and abnormal deep sensory function. EMG and nerve conduction studies in a few individuals showed sensorimotor axonal neuropathy. <i>Pes cavus</i> is described in one individual. Several adults also had muscle atrophy and lower-limb weakness.</p><p><b>Oculomotor findings</b> have included horizontal macro-saccadic pursuits and square wave jerks. These two entities are often confused and macro-saccadic oscillations are more typical of a cerebellar involvement. In addition, individuals presented with jerky pursuit, hypermetric saccades, and gaze-evoked nystagmus.</p><p><b>Seizures.</b> Three individuals were reported to have childhood-onset seizures. No further details about seizure type or EEG findings were available. One individual was treated with phenobarbital and diazepam.</p><p><b>Brain MRI findings</b> can be striking, but imaging results vary among individuals with <i>VPS13D</i> movement disorder. Reported findings include symmetric T<sub>2</sub>-weighted and FLAIR hyperintensities in the caudate and putamen, hyperintense T<sub>2</sub>-weighted and FLAIR signal abnormalities of periventricular and subcortical regions, hypointense basal ganglia (globus pallidus), thin corpus callosum [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>], and mild cerebellar atrophy, often involving the vermis [<a class="bk_pop" href="#vps13d-md.REF.seong.2018.1075">Seong et al 2018</a>]. Imaging findings can resemble those seen in <a href="/books/n/gene/narp/">Leigh syndrome</a>. Some individuals with <i>VPS13D</i> movement disorder have had normal brain MRI.</p><p><b>Muscle biopsy</b> in one individual showed abnormal subsarcolemmal mitochondrial accumulation and mild lipidosis suggestive of mitochondrial disease. However, enzymatic analysis for respiratory chain function was normal [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>].</p><p><b>Other</b></p><ul><li class="half_rhythm"><div><b>Male infertility</b> associated with azoospermia or oligospermia was reported in two individuals.</div></li><li class="half_rhythm"><div><b>Abnormal head size.</b> Both microcephaly (in 2 individuals) and macrocephaly (1 individual) have been described; no further details were available.</div></li><li class="half_rhythm"><div><b>Hearing loss.</b> One individual was reported to have progressive hearing loss; no further details were available.</div></li></ul></div><div id="vps13d-md.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No clear <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are known.</p></div><div id="vps13d-md.Nomenclature"><h3>Nomenclature</h3><p><i>VPS13D</i> movement disorder was initially described as spinocerebellar ataxia with saccadic intrusions (SCASI) associated with the spinocerebellar ataxia, recessive type 4 (SCAR4) <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> [<a class="bk_pop" href="#vps13d-md.REF.swartz.2002.441">Swartz et al 2002</a>].</p></div><div id="vps13d-md.Prevalence"><h3>Prevalence</h3><p><i>VPS13D</i> movement disorder is rare and has been described in 19 individuals from 12 families. The families are mainly of European descent (French Canadian, German, Dutch, Slovenian, Italian) [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>, <a class="bk_pop" href="#vps13d-md.REF.seong.2018.1075">Seong et al 2018</a>]. One Indonesian and one Egyptian family have also been described [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>, <a class="bk_pop" href="#vps13d-md.REF.seong.2018.1075">Seong et al 2018</a>].</p></div></div><div id="vps13d-md.Genetically_Related_Allelic_Di"><h2 id="_vps13d-md_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>VPS13D</i>.</p></div><div id="vps13d-md.Differential_Diagnosis"><h2 id="_vps13d-md_Differential_Diagnosis_">Differential Diagnosis</h2><div id="vps13d-md.T.disorders_to_consider_in_the" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders to Consider in the Differential Diagnosis of <i>VPS13D</i> Movement Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537720/table/vps13d-md.T.disorders_to_consider_in_the/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps13d-md.T.disorders_to_consider_in_the_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of the Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/<i>VPS13D</i><br />movement disorder</th><th headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4" id="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing from <i>VPS13D</i><br />movement disorder</th></tr></thead><tbody><tr><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spastic ataxia 1&#x000a0;<sup>1</sup></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>VAMP1</i></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spastic ataxic gait</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Adult onset</div></li><li class="half_rhythm"><div>No dystonia</div></li><li class="half_rhythm"><div>Normal brain MRI</div></li></ul>
</td></tr><tr><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spastic ataxia 2&#x000a0;<sup>1</sup></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KIF1C</i></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pediatric-onset spastic ataxic gait</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No extrapyramidal involvement</td></tr><tr><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spastic ataxia 3&#x000a0;<sup>1</sup></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MARS2</i></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Spastic ataxic gait</div></li><li class="half_rhythm"><div>White matter abnormalities</div></li></ul>
</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing impairment</td></tr><tr><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spastic ataxia 4&#x000a0;<sup>1</sup></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MTPAP</i></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spastic ataxia</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropathy w/loss of reflexes</td></tr><tr><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spastic ataxia 5&#x000a0;<sup>1</sup></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AFG3L2</i></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pediatric-onset spastic ataxia</div></li><li class="half_rhythm"><div>Dystonia</div></li></ul>
</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Myoclonic epilepsy</div></li><li class="half_rhythm"><div>Oculomotor apraxia</div></li></ul>
</td></tr><tr><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Leigh syndrome&#x000a0;<sup>2</sup></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Many</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR<br />XL<br />mt</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bilateral basal ganglia lesions</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac or skeletal muscle involvement</td></tr><tr><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hsp/">HSP</a> (incl <a href="/books/n/gene/spg3a/">SPG3A</a>,<br /><a href="/books/n/gene/spg4/">SPG4</a>, SPG7,<br />SPG11)&#x000a0;<sup>3</sup></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATL1</i><br /><i>SPAST</i><br /><i>SPG7</i><br /><i>SPG11</i></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD<br />AR</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pediatric-onset spastic gait</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No cerebellar features</td></tr><tr><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SCAR2&#x000a0;<sup>1</sup></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PMPCA</i></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pediatric-onset ataxic gait</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebellar atrophy</td></tr><tr><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SCAR7&#x000a0;<sup>1</sup></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TPP1</i></td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pediatric-onset ataxic gait</td><td headers="hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_1_4 hd_h_vps13d-md.T.disorders_to_consider_in_the_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Posterior column involvement</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; HSP = hereditary spastic paraplegia; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; mt = mitochondrial</p></div></dd><dt></dt><dd><div><p class="no_margin">SCAR = spinocerebellar ataxia, <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="vps13d-md.TF.2.1"><p class="no_margin">See <a href="/books/n/gene/ataxias/">Hereditary Ataxia Overview</a>.</p></div></dd><dt>2. </dt><dd><div id="vps13d-md.TF.2.2"><p class="no_margin">See <a href="/books/n/gene/narp/">Mitochondrial DNA-Associated Leigh Syndrome and NARP</a>.</p></div></dd><dt>3. </dt><dd><div id="vps13d-md.TF.2.3"><p class="no_margin">These are the more common subtypes of hereditary spastic paraplegia with onset in childhood.</p></div></dd></dl></div></div></div></div><div id="vps13d-md.Management"><h2 id="_vps13d-md_Management_">Management</h2><div id="vps13d-md.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>VPS13D</i> movement disorder, the evaluations summarized in <a class="figpopup" href="/books/NBK537720/table/vps13d-md.T.recommended_evaluations_foll/?report=objectonly" target="object" rid-figpopup="figvps13dmdTrecommendedevaluationsfoll" rid-ob="figobvps13dmdTrecommendedevaluationsfoll">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="vps13d-md.T.recommended_evaluations_foll" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with <i>VPS13D</i> Movement Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537720/table/vps13d-md.T.recommended_evaluations_foll/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps13d-md.T.recommended_evaluations_foll_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physiatry &#x00026; physiotherapy evaluation</td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To ensure proper bracing &#x00026; walking aids</td></tr><tr><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation</td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EEG, EMG/NCS if clinically indicated</td></tr><tr><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for macrosaccadic intrusions.</td></tr><tr><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Endocrine</b></td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fertility evaluation in males of reproductive age</td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluate for male infertility, oligospermia.</td></tr><tr><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl evaluation of motor, speech/language, general cognitive, &#x00026; vocational skills</td></tr><tr><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_vps13d-md.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">EEG = electroencephalogram; EMG = electromyogram; NCS = nerve conduction study</p></div></dd></dl></div></div></div></div><div id="vps13d-md.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Seizures.</b> Standardized treatment with antiepileptic drugs (AEDs) by an experienced neurologist. Many different AEDs may be effective, and no one AED has been demonstrated to be effective specifically for this disorder. Education of parents regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</p><p><b>Spasticity.</b> Recommendations for spasticity treatment include baclofen, tizanidine, benzodiazepines, dantrolene sodium, gabapentin, botulinum toxin injections, and intrathecal baclofen, which are established treatments in a similar condition, <a href="/books/n/gene/friedreich/">Friedreich ataxia</a> [<a class="bk_pop" href="#vps13d-md.REF.corben.2014.184">Corben et al 2014</a>].</p><p><b>Dystonia.</b> Treatment options for dystonia include trihexyphenidyl, botulinum toxin injections, benzodiazepines, baclofen, and levodopa [<a class="bk_pop" href="#vps13d-md.REF.jinnah.2015.77">Jinnah &#x00026; Factor 2015</a>]. Deep brain stimulation has not been reported as a treatment for <i>VPS13D</i> hyperkinetic movement disorder.</p><p><b>Ataxia.</b> No specific pharmacologic treatments for ataxia have been approved. Riluzole is probably effective in reducing ataxia symptoms (European Federation of Neurological Societies [EFNS] &#x02013; level B rating) and varenicline is probably effective in improving gait and stance in individuals with <a href="/books/n/gene/sca3/">spinocerebellar ataxia type 3</a> (SCA3) (EFNS &#x02013; level B rating ) [<a class="bk_pop" href="#vps13d-md.REF.van_de_warrenburg.2014.552">van de Warrenburg et al 2014</a>]. Neither of these medications has been tested in individuals with <i>VPS13D</i> spastic ataxia.</p><p>A multidisciplinary team including occupational and physical therapists as well as a physiatrist is important in the care of individuals with this complex movement disorder.</p><div id="vps13d-md.Developmental_Delay__Intellect"><h4>Developmental Delay / Intellectual Disability Educational Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States (US); standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years.</b> In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21. Discussion about transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</p><p><b>Gross motor dysfunction.</b> Physical therapy is recommended to maximize mobility. Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</p><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy, typically from an occupational or speech therapist, is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div></div><div id="vps13d-md.Surveillance"><h3>Surveillance</h3><p>No specific surveillance guidelines exist. The authors recommend following standard ataxia and spasticity guidelines. Care should include regular visits to a neurologist and physiatrist. A speech therapist and a urologist should be consulted when indicated.</p><div id="vps13d-md.T.recommended_surveillance_for" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with <i>VPS13D</i> Movement Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537720/table/vps13d-md.T.recommended_surveillance_for/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps13d-md.T.recommended_surveillance_for_lrgtbl__"><table><thead><tr><th id="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th></tr></thead><tbody><tr><td headers="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ask about urinary urgency.</td></tr><tr><td headers="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor contractures.</td></tr><tr><td headers="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor those w/seizures as clinically indicated; evaluate fall risk &#x00026; gait stability.</td></tr><tr><td headers="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/Other</b></td><td headers="hd_h_vps13d-md.T.recommended_surveillance_for_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitor developmental progress &#x00026; educational needs.</td></tr></tbody></table></div></div></div><div id="vps13d-md.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>No specific agents or circumstances are to be avoided aside from excessive alcohol use, which could worsen ataxia.</p></div><div id="vps13d-md.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from developmental services and/or seizure management when appropriate.</p><p>See <a href="#vps13d-md.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="vps13d-md.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Studies are currently under way to understand the role of <i>VPS13D</i> in mitochondrial integrity and ultimately develop targeted treatments that can enhance mitochondrial function.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="vps13d-md.Genetic_Counseling"><h2 id="_vps13d-md_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="vps13d-md.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>VPS13D</i> movement disorder is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="vps13d-md.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>VPS13D</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Unless an individual with <i>VPS13D</i> movement disorder has children with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, his/her offspring will be obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>VPS13D.</i></p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <i>VPS13D</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="vps13d-md.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>VPS13D</i> pathogenic variants in the family.</p></div><div id="vps13d-md.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#vps13d-md.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="vps13d-md.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>VPS13D</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="vps13d-md.Resources"><h2 id="_vps13d-md_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22234/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Spinocerebellar ataxia</a></div></li></ul></div><div id="vps13d-md.Molecular_Genetics"><h2 id="_vps13d-md_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="vps13d-md.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>VPS13D Movement Disorder: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537720/table/vps13d-md.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps13d-md.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_vps13d-md.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_vps13d-md.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_vps13d-md.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_vps13d-md.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_vps13d-md.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_vps13d-md.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_vps13d-md.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/55187" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>VPS13D</i></a></td><td headers="hd_b_vps13d-md.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=55187" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1p36<wbr style="display:inline-block"></wbr>​.22-p36.21</a></td><td headers="hd_b_vps13d-md.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q5THJ4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Vacuolar protein sorting-associated protein 13D</a></td><td headers="hd_b_vps13d-md.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://databases.lovd.nl/shared/genes/VPS13D" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VPS13D gene homepage - vacuolar protein sorting 13 homolog D</a></td><td headers="hd_b_vps13d-md.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=VPS13D" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VPS13D</a></td><td headers="hd_b_vps13d-md.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=VPS13D[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">VPS13D</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="vps13d-md.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="vps13d-md.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for VPS13D Movement Disorder (<a href="/omim/607317,608877" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537720/table/vps13d-md.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps13d-md.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/607317" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">607317</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608877" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608877</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">VACUOLAR PROTEIN SORTING 13, YEAST, HOMOLOG OF, D; VPS13D</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>VPS13D</i> (NM_015378.3) comprises 69 exons spanning approximately 281,000 nucleotides, and it encodes a 4,388-amino acid protein (NP_056193.2). See <a href="/books/n/gene/VPS13D-rmd/#VPS13D-rmd.molgen.TA">Table A</a>, <b>Gene</b> for a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information.</p><p><b>Pathogenic variants.</b> Pathogenic variants consist of <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, frameshift, protein-truncating, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants that are located throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Although <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have not been established, the more severe, early-onset hypotonia/dystonia with developmental delay phenotype is associated with a splice site variant or partial-gene <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> combined with a missense variant. However, a severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child with early-onset developmental delay and hypotonia was found to have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> missense variants (p.Thr865Ala; p.Gly1200Asp), one of which lies in a repeating coiled region. The only individual with a <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> missense variant (c.12683G&#x0003e;A; p.Arg4228Gln) had onset of gait instability before age two years and mild intellectual disability [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>].</p><p>In all but one of the 12 reported families, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> pathogenic variants with a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variant and a presumptive milder <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> or <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variant [<a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>, <a class="bk_pop" href="#vps13d-md.REF.seong.2018.1075">Seong et al 2018</a>]. No whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> has been reported to date.</p><div id="vps13d-md.T.vps13d_variants_discussed_in" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>VPS13D</i> Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537720/table/vps13d-md.T.vps13d_variants_discussed_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__vps13d-md.T.vps13d_variants_discussed_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.2593A&#x0003e;G</td><td headers="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Thr865Ala</td><td headers="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_015378.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_015378<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_056193.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_056193<wbr style="display:inline-block"></wbr>​.2</a></td></tr><tr><td headers="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.3599G&#x0003e;A</td><td headers="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">p.Gly1200Asp</td></tr><tr><td headers="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">c.12683G&#x0003e;A</td><td headers="hd_h_vps13d-md.T.vps13d_variants_discussed_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:bottom;">p.Arg4228Gln</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The 4,388-amino acid VPS13D protein is predicted to have several domains:</p><ul><li class="half_rhythm"><div>N1 or chorein <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (aa 2-115)</div></li><li class="half_rhythm"><div>VPS13 2nd N-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (aa 137-356)</div></li><li class="half_rhythm"><div>Repeat coiled region <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (aa 613-901)</div></li><li class="half_rhythm"><div>UBA (ubiquitin-associated) <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (aa 2627-2679)</div></li><li class="half_rhythm"><div>SHR <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (aa 3276-3558)</div></li><li class="half_rhythm"><div>VPS13 C-terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (aa 3983-4129)</div></li></ul><p>The UBA <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> is the only domain unique to VPS13D compared to the other VPS13 family members and is thought to be important for ubiquitin binding. Studies suggest that VPS13D is involved in mitochondrial fission and fusion [<a class="bk_pop" href="#vps13d-md.REF.anding.2018.287">Anding et al 2018</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants are thought to cause disease by altering mitochondrial function. In most reported individuals, a <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variant is combined with a seemingly milder variant.</p><p>Abnormal mitochondrial morphology has been demonstrated in cell lines of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Interestingly, <i>VPS13D</i> knockout models in <i>Drosophila</i> and mouse models are not compatible with life (embryonic lethal) [<a class="bk_pop" href="#vps13d-md.REF.anding.2018.287">Anding et al 2018</a>, <a class="bk_pop" href="#vps13d-md.REF.gauthier.2018.1089">Gauthier et al 2018</a>, <a class="bk_pop" href="#vps13d-md.REF.seong.2018.1075">Seong et al 2018</a>]. Furthermore, cell lines from affected individuals showed reduced mitochondrial function [<a class="bk_pop" href="#vps13d-md.REF.seong.2018.1075">Seong et al 2018</a>].</p></div><div id="vps13d-md.References"><h2 id="_vps13d-md_References_">References</h2><div id="vps13d-md.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="vps13d-md.REF.anding.2018.287">Anding AL, Wang C, Chang TK, Sliter DA, Powers CM, Hofmann K, Youle RJ, Baehrecke EH. Vps13D encodes a ubiquitin-binding protein that is required for the regulation of mitochondrial size and clearance. <span><span class="ref-journal">Curr Biol. </span>2018;<span class="ref-vol">28</span>:287–95.e6.</span> [<a href="/pmc/articles/PMC5787036/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5787036</span></a>] [<a href="/pubmed/29307555" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29307555</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps13d-md.REF.corben.2014.184">Corben LA, Lynch D, Pandolfo M, Schulz JB, Delatycki MB, et al.  Consensus clinical management guidelines for Friedreich ataxia. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2014;<span class="ref-vol">9</span>:184.</span> [<a href="/pmc/articles/PMC4280001/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4280001</span></a>] [<a href="/pubmed/25928624" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25928624</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps13d-md.REF.gauthier.2018.1089">Gauthier J, Meijer IA, Lessel D, Mencacci NE, Krainc D, Hempel M, Tsiakas K, Prokisch H, Rossignol E, Helm MH, Rodan LH, Karamchandani J, Carecchio M, Lubbe SJ, Telegrafi A, Henderson LB, Lorenzo K, Wallace SE, Glass IA, Hamdan FF, Michaud JL, Rouleau GA, Campeau PM. Recessive mutations in &#x0003e;VPS13D cause childhood onset movement disorders. <span><span class="ref-journal">Ann Neurol. </span>2018;<span class="ref-vol">83</span>:1089–95.</span> [<a href="/pubmed/29518281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29518281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps13d-md.REF.jinnah.2015.77">Jinnah HA, Factor SA. Diagnosis and treatment of dystonia. <span><span class="ref-journal">Neurol Clin. </span>2015;<span class="ref-vol">33</span>:77–100.</span> [<a href="/pmc/articles/PMC4248237/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4248237</span></a>] [<a href="/pubmed/25432724" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25432724</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps13d-md.REF.seong.2018.1075">Seong E, Insolera R, Dulovic M, Kamsteeg EJ, Trinh J, Br&#x000fc;ggemann N, Sandford E, Li S, Ozel AB, Li JZ, Jewett T, Kievit AJA, M&#x000fc;nchau A, Shakkottai V, Klein C, Collins CA, Lohmann K, van de Warrenburg BP, Burmeister M. Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects. <span><span class="ref-journal">Ann Neurol. </span>2018;<span class="ref-vol">83</span>:1075–88.</span> [<a href="/pmc/articles/PMC6105379/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6105379</span></a>] [<a href="/pubmed/29604224" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29604224</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps13d-md.REF.swartz.2002.441">Swartz BE, Burmeister M, Somers JT, Rottach KG, Bespalova IN, Leigh RJ. A form of inherited cerebellar ataxia with saccadic intrusions, increased saccadic speed, sensory neuropathy, and myoclonus. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2002;<span class="ref-vol">956</span>:441–4.</span> [<a href="/pubmed/11960835" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11960835</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="vps13d-md.REF.van_de_warrenburg.2014.552">van de Warrenburg BP, van Gaalen J, Boesch S, Burgunder JM, D&#x000fc;rr A, Giunti P, Klockgether T, Mariotti C, Pandolfo M, Riess O. EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. <span><span class="ref-journal">Eur J Neurol. </span>2014;<span class="ref-vol">21</span>:552–62.</span> [<a href="/pubmed/24418350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24418350</span></a>]</div></li></ul></div></div><div id="vps13d-md.Chapter_Notes"><h2 id="_vps13d-md_Chapter_Notes_">Chapter Notes</h2><div id="vps13d-md.Author_Notes"><h3>Author Notes</h3><p>The author recently joined the pediatric neurology team and the research center at CHU Sainte Justine, Montreal. As a clinician researcher specializing in pediatric movement disorders, she focuses on expanding our understanding of the genetic basis of pediatric movement disorders including Tourette syndrome and dystonia. Ongoing research includes investigating the role of mitochondria in the <i>VPS13D</i> movement disorder. This work will ultimately lead to improved diagnosis and care for children with complex movement disorders.</p></div><div id="vps13d-md.Acknowledgments"><h3>Acknowledgments</h3><p>We would like to thank the families for their participation in these studies as well as the various groups who collaborated on this project.</p></div><div id="vps13d-md.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 February 2019 (sw) Review posted live</div></li><li class="half_rhythm"><div>25 July 2018 (im) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK537720</span><span class="label">PMID: <a href="/pubmed/30789691" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">30789691</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/vldlr-ch/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/vps35-pd/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK537720&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK537720/?report=reader">PubReader</a></li><li><a href="/books/NBK537720/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK537720" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK537720" style="display:none" title="Cite this Page"><div class="bk_tt">Meijer IA. VPS13D Movement Disorder. 2019 Feb 21. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK537720/pdf/Bookshelf_NBK537720.pdf">PDF version of this page</a> (193K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#vps13d-md.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#vps13d-md.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#vps13d-md.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#vps13d-md.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#vps13d-md.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#vps13d-md.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#vps13d-md.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#vps13d-md.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#vps13d-md.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#vps13d-md.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#vps13d-md.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=55187[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">VPS13D</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4725748" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4725748" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4725748" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4725748" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301718" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLA2G6</i>-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Kurian MA, Maher ER, Hogarth P, Hayflick SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28749637" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC6A3</i>-Related Dopamine Transporter Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">SLC6A3</i>-Related Dopamine Transporter Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kurian MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301286" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 7</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spastic Paraplegia 7<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Casari G, Marconi R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21735565" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fatty Acid Hydroxylase-Associated Neurodegeneration</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fatty Acid Hydroxylase-Associated Neurodegeneration<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gregory A, Venkateswaran S, Hayflick SJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28541650" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SLC39A14 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> SLC39A14 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Tuschl K, Gregory A, Meyer E, Clayton PT, Hayflick SJ, Mills PB, Kurian MA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=30789691" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=30789691" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040c44dde08911693ee724">VPS13D Movement Disorder - GeneReviews®</a><div class="ralinkpop offscreen_noflow">VPS13D Movement Disorder - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:26:28-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D2DFDE03FE9E100000000055101B2&amp;ncbi_session=CE8D2DFDE040C441_1361SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK537720%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK537720&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK537720/&amp;ncbi_pagename=VPS13D Movement Disorder - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D2DFDE040C441_1361SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>